The MedPAC Blog

  • Price growth of brand-name drugs and Part D

    by MedPAC Staff | Jan 27, 2016
    Evidence suggests that price growth for brand-name drugs is beginning to drive growth in average prices of all drugs covered under Part D.
    Full post
  • MedPAC examines MA and Part D plan accessibility

    by MedPAC Staff | Jan 19, 2016
    Every year, the Commission provides a status report on the Medicare Advantage (MA) and Part D programs. These reports were presented at our December and January meetings. To monitor each program’s performance, we examine enrollment trends, and plan availability for the coming year, as well as a variety of other factors.
    Full post
  • Slow growth in Part D premiums is only part of the story

    by MedPAC Staff | Sep 01, 2015
    At the end of July, CMS announced that enrollee premiums for Medicare’s outpatient prescription drug benefit, known as Part D, will remain stable for 2016 at an average of $32.50 per month. It marks continued good news for Part D enrollees, whose average premiums have remained at about $30 to $32 per month for the past 7 years. However, other trends are more worrisome for the taxpayers supporting the Part D program.
    Full post
  • Opioid use among Medicare Part D enrollees

    by MedPAC Staff | Oct 22, 2014
    At MedPAC’s October public meeting, the Commission discussed patterns of potentially inappropriate opioid use in Medicare’s prescription drug benefit, Part D. In 2011, 10 million beneficiaries, or about 32 percent of Part D enrollees filled at least one prescription for an opioid. The share of Part D enrollees who use opioids in varies considerably across states.
    Full post
  • Explainer: Risk sharing mechanisms in Part D

    by MedPAC Staff | Oct 15, 2014
    At MedPAC’s public meeting last week, the Commission discussed how Medicare shares financial risk with Part D prescription drug plans.
    Full post

Next Public Meeting

PRESS ROOM

For the latest news and press releases from MedPAC


Click Here

Join Our Mailing List

Sign up to recieve e-mail notices of Commission meetings and new posts to our website.

Sign Up Now

Filter posts by subject